Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status
European Journal of Cancer2021Vol. 155, pp. 1–12
Citations Over TimeTop 10% of 2021 papers
Alexander Hein, Andreas D. Hartkopf, Julius Emons, Michael P. Lux, Bernhard Volz, Florin‐Andrei Taran, Friedrich Overkamp, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Lena A. Wurmthaler, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Pauline Wimberger, Carsten Hielscher, Christian M. Kurbacher, Rachel Wuerstlein, Christoph Thomssen, Michael Untch, Peter A. Fasching, Wolfgang Janni, Tanja Fehm, D. Wallwiener, Sara Y. Brucker, Andreas Schneeweiß, Hans‐Christian Kolberg
Related Papers
- → The Prognostic Value of Survivin Expression in Patients with Colorectal Carcinoma: A Meta-analysis(2013)27 cited
- → Survival impact of compliance in extra-perigastric lymphadenectomy for gastric cancer: 20 years of real-world data from a single institution(2022)7 cited
- → Glucosylsphingosine concentration is the most reliable response-parameter for low-dose ERT in homozygous N370S Gaucher patients(2018)
- → Clinical characteristics, genotype and outcome of Gaucher disease in Pakistani children(2019)
- → [The relationship between hazard ratio and median survival time].(2019)